Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
of 32 34 32 34 O
< 35 36 35 36 O
1.5×109 37 44 37 44 B-upper_bound
/ 44 45 44 45 I-upper_bound
L 45 46 45 46 I-upper_bound

Alanine 0 7 47 54 B-treatment
aminotransaminase 8 25 55 72 I-treatment
( 26 27 73 74 I-treatment
ALT 27 30 74 77 I-treatment
) 30 31 77 78 I-treatment

At 0 2 79 81 O
least 3 8 82 87 O
18 9 11 88 90 B-lower_bound
years 12 17 91 96 I-lower_bound
old 18 21 97 100 O

Brain 0 5 101 106 B-cancer
metastases 6 16 107 117 I-cancer
and/or 17 23 118 124 O
spinal 24 30 125 131 B-chronic_disease
cord 31 35 132 136 I-chronic_disease
compression 36 47 137 148 I-chronic_disease
untreated 48 57 149 158 O
with 58 62 159 163 O
surgery 63 70 164 171 B-treatment
and/or 71 77 172 178 O
radiotherapy 78 90 179 191 B-treatment
, 90 91 191 192 O
and 92 95 193 196 O
without 96 103 197 204 O
clinical 104 112 205 213 O
imaging 113 120 214 221 O
evidence 121 129 222 230 O
of 130 132 231 233 O
stable 133 139 234 240 B-cancer
disease 140 147 241 248 I-cancer
for 148 151 249 252 O
14 152 154 253 255 B-lower_bound
days 155 159 256 260 I-lower_bound
or 160 162 261 263 I-lower_bound
longer 163 169 264 270 I-lower_bound
; 169 170 270 271 O
Subjects 171 179 272 280 O
requiring 180 189 281 290 O
steroids 190 198 291 299 B-treatment
within 199 205 300 306 O
4 206 207 307 308 B-upper_bound
weeks 208 213 309 314 I-upper_bound
prior 214 219 315 320 I-upper_bound
to 220 222 321 323 O
start 223 228 324 329 O
of 229 231 330 332 O
study 232 237 333 338 B-treatment
treatment 238 247 339 348 I-treatment

Clinically 0 10 349 359 O
significant 11 22 360 371 O
abnormal 23 31 372 380 B-chronic_disease
serum 32 37 381 386 I-chronic_disease
potassium 38 47 387 396 I-chronic_disease
( 48 49 397 398 O
regardless 49 59 398 408 O
of 60 62 409 411 O
potassium 63 72 412 421 B-treatment
agent 73 78 422 427 I-treatment
supplementation 79 94 428 443 I-treatment
) 94 95 443 444 O
; 95 96 444 445 O
serum 97 102 446 451 B-chronic_disease
calcium 103 110 452 459 I-chronic_disease
( 111 112 460 461 O
ionic 112 117 461 466 O
or 118 120 467 469 O
binding 121 128 470 477 O
to 129 131 478 480 O
albumin 132 139 481 488 O
post 140 144 489 493 O
- 144 145 493 494 O
adjusted 145 153 494 502 O
) 153 154 502 503 O
or 155 157 504 506 O
serum 158 163 507 512 B-chronic_disease
magnesium 164 173 513 522 I-chronic_disease
( 174 175 523 524 O
regardless 175 185 524 534 O
of 186 188 535 537 O
magnesium 189 198 538 547 B-treatment
agent 199 204 548 553 I-treatment
supplementation 205 220 554 569 I-treatment
) 220 221 569 570 O

Clinically 0 10 571 581 O
significant 11 22 582 593 O
cardiovascular 23 37 594 608 B-chronic_disease
disease 38 45 609 616 I-chronic_disease
, 45 46 616 617 O
including 47 56 618 627 O
but 57 60 628 631 O
not 61 64 632 635 O
limited 65 72 636 643 O
to 73 75 644 646 O
, 75 76 646 647 O
acute 77 82 648 653 B-chronic_disease
myocardial 83 93 654 664 I-chronic_disease
infarction 94 104 665 675 I-chronic_disease
within 105 111 676 682 O
6 112 113 683 684 B-upper_bound
months 114 120 685 691 I-upper_bound
prior 121 126 692 697 I-upper_bound
to 127 129 698 700 O
enrollment 130 140 701 711 O

Currently 0 9 712 721 O
use 10 13 722 725 O
medications 14 25 726 737 B-treatment
known 26 31 738 743 O
to 32 34 744 746 O
cause 35 40 747 752 O
QT 41 43 753 755 O
prolongation 44 56 756 768 O
or 57 59 769 771 O
Torsades 60 68 772 780 O
de 69 71 781 783 O
Pointes 72 79 784 791 O

Eastern 0 7 792 799 B-clinical_variable
Cooperative 8 19 800 811 I-clinical_variable
Oncology 20 28 812 820 I-clinical_variable
Group 29 34 821 826 I-clinical_variable
( 35 36 827 828 I-clinical_variable
ECOG 36 40 828 832 I-clinical_variable
) 40 41 832 833 I-clinical_variable
performance 42 53 834 845 I-clinical_variable
status 54 60 846 852 I-clinical_variable
of 61 63 853 855 O
0 64 65 856 857 B-lower_bound
or 66 68 858 860 O
1 69 70 861 862 B-upper_bound

Evidence 0 8 863 871 O
of 9 11 872 874 O
ongoing 12 19 875 882 O
or 20 22 883 885 O
active 23 29 886 892 B-chronic_disease
infection 30 39 893 902 I-chronic_disease
requiring 40 49 903 912 O
intravenous 50 61 913 924 B-treatment
antibiotics 62 73 925 936 I-treatment

Expected 0 8 937 945 B-clinical_variable
survival 9 17 946 954 I-clinical_variable
of 18 20 955 957 O
more 21 25 958 962 O
than 26 30 963 967 O
12 31 33 968 970 B-lower_bound
weeks 34 39 971 976 I-lower_bound

Histologically 0 14 977 991 O
or 15 17 992 994 O
cytologically 18 31 995 1008 O
documented 32 42 1009 1019 O
, 42 43 1019 1020 O
locally 44 51 1021 1028 O
advanced 52 60 1029 1037 O
or 61 63 1038 1040 O
metastatic 64 74 1041 1051 B-cancer
solid 75 80 1052 1057 I-cancer
malignancy 81 91 1058 1068 I-cancer
of 92 94 1069 1071 O
any 95 98 1072 1075 O
type 99 103 1076 1080 O
during 104 110 1081 1087 O
the 111 114 1088 1091 O
dose 115 119 1092 1096 O
escalation 120 130 1097 1107 O
phase 131 136 1108 1113 O
, 136 137 1113 1114 O
that 138 142 1115 1119 O
has 143 146 1120 1123 O
progressed 147 157 1124 1134 O
on 158 160 1135 1137 O
available 161 170 1138 1147 O
standard 171 179 1148 1156 B-treatment
systemic 180 188 1157 1165 I-treatment
therapy 189 196 1166 1173 I-treatment

History 0 7 1174 1181 O
or 8 10 1182 1184 O
presence 11 19 1185 1193 O
of 20 22 1194 1196 O
digestive 23 32 1197 1206 B-chronic_disease
tract 33 38 1207 1212 I-chronic_disease
diseases 39 47 1213 1221 I-chronic_disease
, 47 48 1221 1222 O
including 49 58 1223 1232 O
active 59 65 1233 1239 O
gastric 66 73 1240 1247 B-chronic_disease
/ 73 74 1247 1248 O
duodenal 74 82 1248 1256 B-chronic_disease
ulcer 83 88 1257 1262 I-chronic_disease
or 89 91 1263 1265 O
ulcerative 92 102 1266 1276 B-chronic_disease
colitis 103 110 1277 1284 I-chronic_disease
, 110 111 1284 1285 O
or 112 114 1286 1288 O
active 115 121 1289 1295 B-chronic_disease
hemorrhage 122 132 1296 1306 I-chronic_disease
of 133 135 1307 1309 O
an 136 138 1310 1312 O
unresected 139 149 1313 1323 O
gastrointestinal 150 166 1324 1340 B-cancer
tumor 167 172 1341 1346 I-cancer
, 172 173 1346 1347 O
or 174 176 1348 1350 O
an 177 179 1351 1353 O
evaluation 180 190 1354 1364 O
by 191 193 1365 1367 O
investigators 194 207 1368 1381 O
of 208 210 1382 1384 O
having 211 217 1385 1391 O
any 218 221 1392 1395 O
other 222 227 1396 1401 O
condition 228 237 1402 1411 O
that 238 242 1412 1416 O
could 243 248 1417 1422 O
possibly 249 257 1423 1431 O
result 258 264 1432 1438 O
in 265 267 1439 1441 O
gastrointestinal 268 284 1442 1458 B-chronic_disease
tract 285 290 1459 1464 I-chronic_disease
hemorrhage 291 301 1465 1475 I-chronic_disease
or 302 304 1476 1478 O
perforation 305 316 1479 1490 B-chronic_disease

Inability 0 9 1491 1500 O
to 10 12 1501 1503 O
take 13 17 1504 1508 O
medication 18 28 1509 1519 B-treatment
orally 29 35 1520 1526 O
, 35 36 1526 1527 O
dysphagia 37 46 1528 1537 B-chronic_disease
or 47 49 1538 1540 O
an 50 52 1541 1543 O
active 53 59 1544 1550 O
gastric 60 67 1551 1558 B-chronic_disease
ulcer 68 73 1559 1564 I-chronic_disease
resulting 74 83 1565 1574 O
from 84 88 1575 1579 O
previous 89 97 1580 1588 B-treatment
surgery 98 105 1589 1596 I-treatment
or 106 108 1597 1599 O
a 109 110 1600 1601 O
severe 111 117 1602 1608 O
gastrointestinal 118 134 1609 1625 B-chronic_disease
disease 135 142 1626 1633 I-chronic_disease
, 142 143 1633 1634 O
or 143 145 1634 1636 O
any 146 149 1637 1640 O
other 150 155 1641 1646 O
condition 156 165 1647 1656 O
that 166 170 1657 1661 O
investigators 171 184 1662 1675 O
believe 185 192 1676 1683 O
may 193 196 1684 1687 O
affect 197 203 1688 1694 O
absorption 204 214 1695 1705 O
of 215 217 1706 1708 O
the 218 221 1709 1712 O
investigational 222 237 1713 1728 B-treatment
product 238 245 1729 1736 I-treatment

International 0 13 1737 1750 B-clinical_variable
Normalized 14 24 1751 1761 I-clinical_variable
Ratio 25 30 1762 1767 I-clinical_variable
( 31 32 1768 1769 I-clinical_variable
INR 32 35 1769 1772 I-clinical_variable
) 35 36 1772 1773 I-clinical_variable
> 37 38 1774 1775 O
1.5 39 42 1776 1779 B-lower_bound
ULN 43 46 1780 1783 I-lower_bound

Known 0 5 1784 1789 O
Human 6 11 1790 1795 B-chronic_disease
immunodeficiency 12 28 1796 1812 I-chronic_disease
virus 29 34 1813 1818 I-chronic_disease
( 35 36 1819 1820 I-chronic_disease
HIV 36 39 1820 1823 I-chronic_disease
) 39 40 1823 1824 I-chronic_disease
infection 41 50 1825 1834 I-chronic_disease

Known 0 5 1835 1840 O
clinically 6 16 1841 1851 O
significant 17 28 1852 1863 O
history 29 36 1864 1871 O
of 37 39 1872 1874 O
liver 40 45 1875 1880 B-chronic_disease
disease 46 53 1881 1888 I-chronic_disease
, 53 54 1888 1889 O
including 55 64 1890 1899 O
viral 65 70 1900 1905 B-chronic_disease
or 71 73 1906 1908 O
other 74 79 1909 1914 O
hepatitis 80 89 1915 1924 B-chronic_disease
, 89 90 1924 1925 O
current 91 98 1926 1933 O
alcohol 99 106 1934 1941 O
abuse 107 112 1942 1947 O
, 112 113 1947 1948 O
or 114 116 1949 1951 O
cirrhosis 117 126 1952 1961 B-chronic_disease

Male 0 4 1962 1966 B-gender

Mean 0 4 1967 1971 B-clinical_variable
corrected 5 14 1972 1981 I-clinical_variable
QT 15 17 1982 1984 I-clinical_variable
interval 18 26 1985 1993 I-clinical_variable
( 27 28 1994 1995 I-clinical_variable
QTc 28 31 1995 1998 I-clinical_variable
) 31 32 1998 1999 I-clinical_variable
> 33 34 2000 2001 O
480 35 38 2002 2005 B-lower_bound
msec 39 43 2006 2010 I-lower_bound

Other 0 5 2011 2016 O
disease 6 13 2017 2024 O
, 13 14 2024 2025 O
metabolic 15 24 2026 2035 B-chronic_disease
disorder 25 33 2036 2044 I-chronic_disease
, 33 34 2044 2045 O
physical 35 43 2046 2054 O
examination 44 55 2055 2066 O
anomaly 56 63 2067 2074 O
, 63 64 2074 2075 O
abnormal 65 73 2076 2084 O
laboratory 74 84 2085 2095 O
result 85 91 2096 2102 O
, 91 92 2102 2103 O
or 93 95 2104 2106 O
any 96 99 2107 2110 O
other 100 105 2111 2116 O
condition 106 115 2117 2126 O
that 116 120 2127 2131 O
investigators 121 134 2132 2145 O
suspect 135 142 2146 2153 O
may 143 146 2154 2157 O
prohibit 147 155 2158 2166 O
use 156 159 2167 2170 O
of 160 162 2171 2173 O
the 163 166 2174 2177 O
investigational 167 182 2178 2193 B-treatment
product 183 190 2194 2201 I-treatment
, 190 191 2201 2202 O
affect 192 198 2203 2209 O
interpretation 199 213 2210 2224 O
of 214 216 2225 2227 O
study 217 222 2228 2233 O
results 223 230 2234 2241 O
, 230 231 2241 2242 O
or 232 234 2243 2245 O
put 235 238 2246 2249 O
the 239 242 2250 2253 O
patient 243 250 2254 2261 O
at 251 253 2262 2264 O
high 254 258 2265 2269 O
risk 259 263 2270 2274 O

Palliative 0 10 2275 2285 B-treatment
radiotherapy 11 23 2286 2298 I-treatment
for 24 27 2299 2302 O
bone 28 32 2303 2307 B-cancer
metastasis 33 43 2308 2318 I-cancer
/ 43 44 2318 2319 O
lesion 44 50 2319 2325 O
within 51 57 2326 2332 O
2 58 59 2333 2334 B-upper_bound
weeks 60 65 2335 2340 I-upper_bound
prior 66 71 2341 2346 I-upper_bound
to 72 74 2347 2349 O
the 75 78 2350 2353 O
initiation 79 89 2354 2364 O
of 90 92 2365 2367 O
study 93 98 2368 2373 O
treatment 99 108 2374 2383 B-treatment

Received 0 8 2384 2392 O
investigational 9 24 2393 2408 B-treatment
treatment 25 34 2409 2418 I-treatment
in 35 37 2419 2421 O
another 38 45 2422 2429 B-treatment
clinical 46 54 2430 2438 I-treatment
study 55 60 2439 2444 I-treatment
within 61 67 2445 2451 O
4 68 69 2452 2453 B-upper_bound
weeks 70 75 2454 2459 I-upper_bound
prior 76 81 2460 2465 I-upper_bound
to 82 84 2466 2468 O
the 85 88 2469 2472 O
initiation 89 99 2473 2483 B-treatment
of 100 102 2484 2486 I-treatment
investigational 103 118 2487 2502 I-treatment
treatmen 119 127 2503 2511 I-treatment

Serum 0 5 2512 2517 B-clinical_variable
creatinine 6 16 2518 2528 I-clinical_variable
clearance 17 26 2529 2538 I-clinical_variable
< 27 28 2539 2540 O
60 29 31 2541 2543 B-upper_bound
ml 32 34 2544 2546 I-upper_bound
/ 34 35 2546 2547 I-upper_bound
min 35 38 2547 2550 I-upper_bound
on 39 41 2551 2553 O
the 42 45 2554 2557 O
basis 46 51 2558 2563 O
of 52 54 2564 2566 O
either 55 61 2567 2573 O
24 62 64 2574 2576 O
- 64 65 2576 2577 O
hour 65 69 2577 2581 O
urine 70 75 2582 2587 O
collection 76 86 2588 2598 O
or 87 89 2599 2601 O
the 90 93 2602 2605 O
glomerate 94 103 2606 2615 O
filtration 104 114 2616 2626 O
rate 115 119 2627 2631 O
estimated 120 129 2632 2641 O
by 130 132 2642 2644 O
Cockraft 133 141 2645 2653 O
- 141 142 2653 2654 O
Gault 142 147 2654 2659 O
equation 148 156 2660 2668 O

Serum 0 5 2669 2674 B-clinical_variable
total 6 11 2675 2680 I-clinical_variable
bilirubin 12 21 2681 2690 I-clinical_variable
> 22 23 2691 2692 O
1.5 24 27 2693 2696 B-lower_bound
times 28 33 2697 2702 I-lower_bound
the 34 37 2703 2706 I-lower_bound
upper 38 43 2707 2712 I-lower_bound
limit 44 49 2713 2718 I-lower_bound
of 50 52 2719 2721 I-lower_bound
normal 53 59 2722 2728 I-lower_bound
( 60 61 2729 2730 I-lower_bound
ULN 61 64 2730 2733 I-lower_bound
) 64 65 2733 2734 I-lower_bound

Strong 0 6 2735 2741 B-treatment
inducers 7 15 2742 2750 I-treatment
or 16 18 2751 2753 O
inhibitors 19 29 2754 2764 B-treatment
of 30 32 2765 2767 I-treatment
CYP3A4 33 39 2768 2774 I-treatment
within 40 46 2775 2781 O
2 47 48 2782 2783 B-upper_bound
weeks 49 54 2784 2789 I-upper_bound
before 55 61 2790 2796 O
the 62 65 2797 2800 O
first 66 71 2801 2806 O
dose 72 76 2807 2811 O
of 77 79 2812 2814 O
study 80 85 2815 2820 B-treatment
treatment 86 95 2821 2830 I-treatment
( 96 97 2831 2832 O
3 97 98 2832 2833 B-upper_bound
weeks 99 104 2834 2839 I-upper_bound
for 105 108 2840 2843 O
St 109 111 2844 2846 B-treatment
John‟s 112 118 2847 2853 I-treatment
Wort 119 123 2854 2858 I-treatment
) 123 124 2858 2859 O

Subject 0 7 2860 2867 O
is 8 10 2868 2870 O
currently 11 20 2871 2880 O
receiving 21 30 2881 2890 O
or 31 33 2891 2893 O
intending 34 43 2894 2903 O
to 44 46 2904 2906 O
receive 47 54 2907 2914 O
anti 55 59 2915 2919 B-treatment
- 59 60 2919 2920 I-treatment
coagulants 60 70 2920 2930 I-treatment
for 71 74 2931 2934 O
therapeutic 75 86 2935 2946 O
purposes 87 95 2947 2955 O

Surgery 0 7 2956 2963 B-treatment
prior 8 13 2964 2969 O
to 14 16 2970 2972 O
enrollment 17 27 2973 2983 O
within 28 34 2984 2990 O
28 35 37 2991 2993 B-upper_bound
days 38 42 2994 2998 I-upper_bound
prior 43 48 2999 3004 I-upper_bound
to 49 51 3005 3007 O
the 52 55 3008 3011 O
initiation 56 66 3012 3022 O
of 67 69 3023 3025 O
study 70 75 3026 3031 O
treatment 76 85 3032 3041 B-treatment
or 86 88 3042 3044 O
unhealed 89 97 3045 3053 O
surgical 98 106 3054 3062 O
incision 107 115 3063 3071 O

Systemic 0 8 3072 3080 B-treatment
anti 9 13 3081 3085 I-treatment
- 13 14 3085 3086 I-treatment
neoplastic 14 24 3086 3096 I-treatment
therapies 25 34 3097 3106 I-treatment
within 35 41 3107 3113 O
4 42 43 3114 3115 B-upper_bound
weeks 44 49 3116 3121 I-upper_bound
prior 50 55 3122 3127 I-upper_bound
to 56 58 3128 3130 O
the 59 62 3131 3134 O
initiation 63 73 3135 3145 O
of 74 76 3146 3148 O
investigational 77 92 3149 3164 B-treatment
treatment 93 102 3165 3174 I-treatment
, 102 103 3174 3175 O
including 104 113 3176 3185 O
chemotherapy 114 126 3186 3198 B-treatment
, 126 127 3198 3199 O
radical 128 135 3200 3207 B-treatment
radiotherapy 136 148 3208 3220 I-treatment
, 148 149 3220 3221 O
hormonotherapy 150 164 3222 3236 B-treatment
, 164 165 3236 3237 O
biotherapy 166 176 3238 3248 B-treatment
and 177 180 3249 3252 O
immunotherapy 181 194 3253 3266 B-treatment

Toxicity 0 8 3267 3275 O
from 9 13 3276 3280 O
a 14 15 3281 3282 O
previous 16 24 3283 3291 B-treatment
anti 25 29 3292 3296 I-treatment
- 29 30 3296 3297 I-treatment
tumor 30 35 3297 3302 I-treatment
treatment 36 45 3303 3312 I-treatment
that 46 50 3313 3317 O
does 51 55 3318 3322 O
not 56 59 3323 3326 O
return 60 66 3327 3333 O
to 67 69 3334 3336 O
Grade 70 75 3337 3342 O
0 76 77 3343 3344 B-lower_bound
or 78 80 3345 3347 O
1 81 82 3348 3349 B-upper_bound
( 83 84 3350 3351 O
except 84 90 3351 3357 O
for 91 94 3358 3361 O
alopecia 95 103 3362 3370 B-chronic_disease
) 103 104 3370 3371 O

Uncontrolled 0 12 3372 3384 B-chronic_disease
hypertension 13 25 3385 3397 I-chronic_disease
, 25 26 3397 3398 O
defined 27 34 3399 3406 O
as 35 37 3407 3409 O
: 37 38 3409 3410 O
systolic 39 47 3411 3419 B-clinical_variable
blood 48 53 3420 3425 I-clinical_variable
pressure 54 62 3426 3434 I-clinical_variable
≥ 63 64 3435 3436 O
140 65 68 3437 3440 B-lower_bound
mmHg 69 73 3441 3445 I-lower_bound
and/or 74 80 3446 3452 O
diastolic 81 90 3453 3462 B-clinical_variable
blood 91 96 3463 3468 I-clinical_variable
pressure 97 105 3469 3477 I-clinical_variable
≥ 106 107 3478 3479 O
90 108 110 3480 3482 B-lower_bound
mmHg 111 115 3483 3487 I-lower_bound

Urine 0 5 3488 3493 B-clinical_variable
protein 6 13 3494 3501 I-clinical_variable
> 14 15 3502 3503 O
2 16 17 3504 3505 B-lower_bound
+ 17 18 3505 3506 I-lower_bound
; 18 19 3506 3507 O
Patients 20 28 3508 3516 O
discovered 29 39 3517 3527 O
to 40 42 3528 3530 O
have 43 47 3531 3535 O
≥ 48 49 3536 3537 O
1 50 51 3538 3539 B-lower_bound
+ 51 52 3539 3540 I-lower_bound
proteinuria 53 64 3541 3552 B-chronic_disease
on 65 67 3553 3555 O
dipstick 68 76 3556 3564 O
urinalysis 77 87 3565 3575 O
at 88 90 3576 3578 O
baseline 91 99 3579 3587 O
should 100 106 3588 3594 O
undergo 107 114 3595 3602 O
a 115 116 3603 3604 O
24 117 119 3605 3607 B-upper_bound
- 119 120 3607 3608 I-upper_bound
hour 120 124 3608 3612 I-upper_bound
urine 125 130 3613 3618 O
collection 131 141 3619 3629 O
and 142 145 3630 3633 O
must 146 150 3634 3638 O
demonstrate 151 162 3639 3650 O
< 163 164 3651 3652 O
1 165 166 3653 3654 B-upper_bound
g 167 168 3655 3656 I-upper_bound
of 169 171 3657 3659 I-upper_bound
protein 172 179 3660 3667 I-upper_bound
in 180 182 3668 3670 O
24 183 185 3671 3673 O
- 185 186 3673 3674 O
hour 186 190 3674 3678 O
urine 191 196 3679 3684 O

Women 0 5 3685 3690 B-gender
who 6 9 3691 3694 O
are 10 13 3695 3698 B-pregnancy
pregnant 14 22 3699 3707 I-pregnancy

activated 0 9 3708 3717 B-clinical_variable
partial 10 17 3718 3725 I-clinical_variable
thromboplastin 18 32 3726 3740 I-clinical_variable
time 33 37 3741 3745 I-clinical_variable
( 38 39 3746 3747 I-clinical_variable
aPTT 39 43 3747 3751 I-clinical_variable
) 43 44 3751 3752 I-clinical_variable
> 45 46 3753 3754 O
1.5 47 50 3755 3758 B-lower_bound
ULN 51 54 3759 3762 I-lower_bound

alkaline 0 8 3763 3771 B-clinical_variable
phosphatase 9 20 3772 3783 I-clinical_variable
( 21 22 3784 3785 I-clinical_variable
ALP 22 25 3785 3788 I-clinical_variable
) 25 26 3788 3789 I-clinical_variable
> 27 28 3790 3791 O
2.5 29 32 3792 3795 B-lower_bound
ULN 33 36 3796 3799 I-lower_bound
without 37 44 3800 3807 O
hepatic 45 52 3808 3815 B-cancer
metastases 53 63 3816 3826 I-cancer
or 64 66 3827 3829 O
ALT 67 70 3830 3833 B-clinical_variable
, 70 71 3833 3834 O
AST 72 75 3835 3838 B-clinical_variable
or 76 78 3839 3841 O
ALP 79 82 3842 3845 O
> 83 84 3846 3847 O
5 85 86 3848 3849 O
ULN 87 90 3850 3853 O
with 91 95 3854 3858 O
hepatic 96 103 3859 3866 O
metastases 104 114 3867 3877 O

any 0 3 3878 3881 O
factors 4 11 3882 3889 O
that 12 16 3890 3894 O
increase 17 25 3895 3903 O
the 26 29 3904 3907 O
risk 30 34 3908 3912 O
of 35 37 3913 3915 O
QTc 38 41 3916 3919 O
prolongation 42 54 3920 3932 O
or 55 57 3933 3935 O
risk 58 62 3936 3940 O
of 63 65 3941 3943 O
arrhythmic 66 76 3944 3954 B-chronic_disease
events 77 83 3955 3961 I-chronic_disease
such 84 88 3962 3966 O
as 89 91 3967 3969 O
hypokalaemia 92 104 3970 3982 B-chronic_disease
, 104 105 3982 3983 O
congenital 106 116 3984 3994 B-chronic_disease
long 117 121 3995 3999 I-chronic_disease
QT 122 124 4000 4002 I-chronic_disease
syndrome 125 133 4003 4011 I-chronic_disease
, 133 134 4011 4012 O
family 135 141 4013 4019 O
history 142 149 4020 4027 O
of 150 152 4028 4030 O
long 153 157 4031 4035 O
QT 158 160 4036 4038 O
syndrome 161 169 4039 4047 O
or 170 172 4048 4050 O
unexplained 173 184 4051 4062 O
sudden 185 191 4063 4069 O
death 192 197 4070 4075 O
under 198 203 4076 4081 O
40 204 206 4082 4084 B-upper_bound
years 207 212 4085 4090 I-upper_bound
of 213 215 4091 4093 O
age 216 219 4094 4097 B-age
in 220 222 4098 4100 O
a 223 224 4101 4102 O
next 225 229 4103 4107 O
- 229 230 4107 4108 O
of 230 232 4108 4110 O
- 232 233 4110 4111 O
kin 233 236 4111 4114 O
relative 237 245 4115 4123 O

female 0 6 4124 4130 B-gender
patients 7 15 4131 4139 I-gender
of 16 18 4140 4142 O
child 19 24 4143 4148 O
- 24 25 4148 4149 O
producing 25 34 4149 4158 O
potential 35 44 4159 4168 O
must 45 49 4169 4173 O
agree 50 55 4174 4179 B-contraception_consent
to 56 58 4180 4182 I-contraception_consent
use 59 62 4183 4186 I-contraception_consent
two 63 66 4187 4190 I-contraception_consent
methods 67 74 4191 4198 I-contraception_consent
of 75 77 4199 4201 I-contraception_consent
the 78 81 4202 4205 I-contraception_consent
following 82 91 4206 4215 I-contraception_consent
contraceptive 92 105 4216 4229 I-contraception_consent
: 105 106 4229 4230 O
condoms 107 114 4231 4238 B-contraception_consent
, 114 115 4238 4239 O
intrauterine 115 127 4239 4251 B-contraception_consent
device 128 134 4252 4258 I-contraception_consent
( 135 136 4259 4260 I-contraception_consent
IUD 136 139 4260 4263 I-contraception_consent
) 139 140 4263 4264 I-contraception_consent
, 140 141 4264 4265 O
contraceptives 142 156 4266 4280 B-contraception_consent
( 157 158 4281 4282 I-contraception_consent
oral 158 162 4282 4286 I-contraception_consent
or 163 165 4287 4289 I-contraception_consent
parenteral 166 176 4290 4300 I-contraception_consent
) 176 177 4300 4301 I-contraception_consent
, 177 178 4301 4302 O
Implanon 179 187 4303 4311 B-contraception_consent
, 187 188 4311 4312 O
injectables 189 200 4313 4324 B-contraception_consent
during 201 207 4325 4331 O
the 208 211 4332 4335 O
study 212 217 4336 4341 O
and 218 221 4342 4345 O
up 222 224 4346 4348 O
to 225 227 4349 4351 O
90 228 230 4352 4354 B-upper_bound
days 231 235 4355 4359 I-upper_bound
post 236 240 4360 4364 O
the 241 244 4365 4368 O
last 245 249 4369 4373 B-treatment
day 250 253 4374 4377 I-treatment
of 254 256 4378 4380 I-treatment
study 257 262 4381 4386 I-treatment
treatment 263 272 4387 4396 I-treatment

for 0 3 4397 4400 O
whom 4 8 4401 4405 O
no 9 11 4406 4408 O
effective 12 21 4409 4418 O
therapy 22 29 4419 4426 B-treatment
or 30 32 4427 4429 O
standard 33 41 4430 4438 O
of 42 44 4439 4441 O
care 45 49 4442 4446 O
exists 50 56 4447 4453 O

locally 0 7 4454 4461 O
advanced 8 16 4462 4470 O
or 17 19 4471 4473 O
metastatic 20 30 4474 4484 B-cancer
BTC 31 34 4485 4488 I-cancer
that 35 39 4489 4493 O
has 40 43 4494 4497 O
progressed 44 54 4498 4508 O
on 55 57 4509 4511 O
standard 58 66 4512 4520 O
ﬁrst 67 71 4521 4525 O
- 71 72 4525 4526 O
line 72 76 4526 4530 O
chemotherapy 77 89 4531 4543 B-treatment
, 89 90 4543 4544 O

locally 0 7 4545 4552 O
advanced 8 16 4553 4561 O
or 17 19 4562 4564 O
metastatic 20 30 4565 4575 B-cancer
pNET 31 35 4576 4580 I-cancer
that 36 40 4581 4585 O
has 41 44 4586 4589 O
progressed 45 55 4590 4600 O
on 56 58 4601 4603 O
everolimus 59 69 4604 4614 B-treatment
, 69 70 4614 4615 O
sunitinib 71 80 4616 4625 B-treatment
or 81 83 4626 4628 O
both 84 88 4629 4633 O
, 88 89 4633 4634 O
during 90 96 4635 4641 O
the 97 100 4642 4645 O
expansion 101 110 4646 4655 O
phase 111 116 4656 4661 O

platelet 0 8 4662 4670 B-clinical_variable
count 9 14 4671 4676 I-clinical_variable
of 15 17 4677 4679 O
< 18 19 4680 4681 O
100 20 23 4682 4685 B-upper_bound
×109 24 28 4686 4690 I-upper_bound
/ 28 29 4690 4691 I-upper_bound
L 29 30 4691 4692 I-upper_bound
, 30 31 4692 4693 O
or 32 34 4694 4696 O
hemoglobin 35 45 4697 4707 B-clinical_variable
< 46 47 4708 4709 O
9g 48 50 4710 4712 B-upper_bound
/ 50 51 4712 4713 I-upper_bound
dL 51 53 4713 4715 I-upper_bound

severe 0 6 4716 4722 O
/ 6 7 4722 4723 O
unstable 7 15 4723 4731 B-chronic_disease
angina 16 22 4732 4738 I-chronic_disease
pectoris 23 31 4739 4747 O
or 32 34 4748 4750 O
coronary 35 43 4751 4759 B-treatment
artery 44 50 4760 4766 I-treatment
bypass 51 57 4767 4773 I-treatment
grafting 58 66 4774 4782 I-treatment
, 66 67 4782 4783 O
New 68 71 4784 4787 B-clinical_variable
York 72 76 4788 4792 I-clinical_variable
Heart 77 82 4793 4798 I-clinical_variable
Association 83 94 4799 4810 I-clinical_variable
Class 95 100 4811 4816 B-lower_bound
III 101 104 4817 4820 I-lower_bound
/ 104 105 4820 4821 O
IV 105 107 4821 4823 B-upper_bound
congestive 108 118 4824 4834 B-chronic_disease
heart 119 124 4835 4840 I-chronic_disease
failure 125 132 4841 4848 I-chronic_disease
, 132 133 4848 4849 O
ventricular 134 145 4850 4861 B-chronic_disease
arrhythmias 146 157 4862 4873 I-chronic_disease
requiring 158 167 4874 4883 O
treatment 168 177 4884 4893 B-treatment
or 178 180 4894 4896 O
left 181 185 4897 4901 B-clinical_variable
ventricular 186 197 4902 4913 I-clinical_variable
ejection 198 206 4914 4922 I-clinical_variable
fraction 207 215 4923 4931 I-clinical_variable
( 216 217 4932 4933 I-clinical_variable
LVEF 217 221 4933 4937 I-clinical_variable
) 221 222 4937 4938 I-clinical_variable
< 223 224 4939 4940 O
50 225 227 4941 4943 B-upper_bound
% 227 228 4943 4944 I-upper_bound

